CN105434477B - 脆弱拟杆菌在抗水产病原菌中的应用 - Google Patents
脆弱拟杆菌在抗水产病原菌中的应用 Download PDFInfo
- Publication number
- CN105434477B CN105434477B CN201510727741.4A CN201510727741A CN105434477B CN 105434477 B CN105434477 B CN 105434477B CN 201510727741 A CN201510727741 A CN 201510727741A CN 105434477 B CN105434477 B CN 105434477B
- Authority
- CN
- China
- Prior art keywords
- bacteroides fragilis
- vibrio
- pathogenic bacterium
- aquatic pathogenic
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000606124 Bacteroides fragilis Species 0.000 title claims abstract description 131
- 244000052616 bacterial pathogen Species 0.000 title claims abstract description 33
- 241000894006 Bacteria Species 0.000 claims abstract description 42
- 241000607598 Vibrio Species 0.000 claims abstract description 27
- 239000006166 lysate Substances 0.000 claims abstract description 15
- 241000544286 Vibrio anguillarum Species 0.000 claims abstract description 14
- 239000012228 culture supernatant Substances 0.000 claims abstract description 14
- 241000607618 Vibrio harveyi Species 0.000 claims abstract description 13
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 12
- 230000002779 inactivation Effects 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 6
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 4
- 241000606125 Bacteroides Species 0.000 claims description 5
- 241000682973 Quasibacillus Species 0.000 claims description 5
- 238000009360 aquaculture Methods 0.000 abstract description 15
- 244000144974 aquaculture Species 0.000 abstract description 13
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 230000002401 inhibitory effect Effects 0.000 abstract description 8
- 206010059866 Drug resistance Diseases 0.000 abstract description 6
- 231100000252 nontoxic Toxicity 0.000 abstract description 4
- 230000003000 nontoxic effect Effects 0.000 abstract description 4
- 239000006041 probiotic Substances 0.000 description 15
- 235000018291 probiotics Nutrition 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 230000009286 beneficial effect Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000002504 physiological saline solution Substances 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000000529 probiotic effect Effects 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000235342 Saccharomycetes Species 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 201000009032 substance abuse Diseases 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 244000235858 Acetobacter xylinum Species 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241001656810 Clostridium aceticum Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 241000194035 Lactococcus lactis Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 241000108664 Nitrobacteria Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000000443 biocontrol Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 229960002588 cefradine Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- RDLPVSKMFDYCOR-UEKVPHQBSA-N cephradine Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CCC=CC1 RDLPVSKMFDYCOR-UEKVPHQBSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000010815 organic waste Substances 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012629 purifying agent Substances 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Abstract
Description
副溶血弧菌 | 灿烂弧菌 | 哈氏弧菌 | 鳗弧菌 | 铜绿假单胞菌 | |
ZY-312 | +++ | +++ | ++ | +++ | ++ |
Bd312 | +++ | ++ | +++ | +++ | + |
ATCC25285 | +++ | ++ | +++ | +++ | ++ |
PBS | - | - | - | - | - |
副溶血弧菌 | 灿烂弧菌 | 哈氏弧菌 | 鳗弧菌 | 铜绿假单胞菌 | |
活菌体 | +++ | +++ | ++ | +++ | ++ |
灭活菌体 | ++ | + | ++ | ++ | + |
裂解液 | +++ | +++ | ++ | ++ | ++ |
培养上清 | +++ | ++ | +++ | +++ | + |
PBS | - | - | - | - | - |
Claims (4)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510727741.4A CN105434477B (zh) | 2015-10-29 | 2015-10-29 | 脆弱拟杆菌在抗水产病原菌中的应用 |
PCT/CN2016/092384 WO2017071346A1 (zh) | 2015-10-29 | 2016-07-29 | 脆弱拟杆菌在抗水产病原菌中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510727741.4A CN105434477B (zh) | 2015-10-29 | 2015-10-29 | 脆弱拟杆菌在抗水产病原菌中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105434477A CN105434477A (zh) | 2016-03-30 |
CN105434477B true CN105434477B (zh) | 2019-03-05 |
Family
ID=55545411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510727741.4A Active CN105434477B (zh) | 2015-10-29 | 2015-10-29 | 脆弱拟杆菌在抗水产病原菌中的应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105434477B (zh) |
WO (1) | WO2017071346A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106387314B (zh) * | 2015-07-31 | 2020-11-06 | 广州普维君健药业有限公司 | 脆弱拟杆菌在动物养殖中的应用 |
CN105434477B (zh) * | 2015-10-29 | 2019-03-05 | 广州普维君健药业有限公司 | 脆弱拟杆菌在抗水产病原菌中的应用 |
CN107625791A (zh) * | 2016-07-18 | 2018-01-26 | 广州知易生物科技有限公司 | 脆弱拟杆菌在制备抑制艰难梭菌粘附的组合物中的应用 |
CN107629977A (zh) * | 2016-07-18 | 2018-01-26 | 广州普维君健药业有限公司 | 脆弱拟杆菌在制备防治副溶血弧菌感染的组合物中的应用 |
CN109793761B (zh) * | 2017-11-17 | 2021-03-05 | 瑞微(深圳)生物科技有限公司 | 一种用于增强t细胞免疫功能的组合物及其制备方法 |
CN109908184A (zh) * | 2017-12-12 | 2019-06-21 | 中山大学 | 脆弱拟杆菌在制备用于诱导γδT细胞增殖和/或积累的药物中的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056314A (zh) * | 1990-05-03 | 1991-11-20 | 张李阶 | 一株有益菌株及其应用 |
JP2012180289A (ja) * | 2011-02-28 | 2012-09-20 | Morinaga Milk Ind Co Ltd | 抗菌剤 |
CN103156888A (zh) * | 2013-03-18 | 2013-06-19 | 广州知光生物科技有限公司 | 脆弱拟杆菌在制备治疗炎症性肠病组合物中的应用 |
CN106399141A (zh) * | 2015-07-31 | 2017-02-15 | 广州知易生物科技有限公司 | 一种脆弱拟杆菌及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101845425B (zh) * | 2010-05-25 | 2012-07-04 | 中国人民解放军军事医学科学院野战输血研究所 | 一种α-半乳糖苷酶及其表达、纯化方法 |
CN103142658A (zh) * | 2013-03-18 | 2013-06-12 | 广州知光生物科技有限公司 | 脆弱拟杆菌在制备治疗急性放射性肠炎组合物中的应用 |
CN103146620A (zh) * | 2013-03-25 | 2013-06-12 | 广州知光生物科技有限公司 | 具有益生菌特性的脆弱拟杆菌 |
CN105434476B (zh) * | 2015-10-29 | 2019-02-15 | 广州知易生物科技有限公司 | 一种脆弱拟杆菌在预防和/或治疗炎症性肠病中的应用 |
CN105434477B (zh) * | 2015-10-29 | 2019-03-05 | 广州普维君健药业有限公司 | 脆弱拟杆菌在抗水产病原菌中的应用 |
-
2015
- 2015-10-29 CN CN201510727741.4A patent/CN105434477B/zh active Active
-
2016
- 2016-07-29 WO PCT/CN2016/092384 patent/WO2017071346A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056314A (zh) * | 1990-05-03 | 1991-11-20 | 张李阶 | 一株有益菌株及其应用 |
JP2012180289A (ja) * | 2011-02-28 | 2012-09-20 | Morinaga Milk Ind Co Ltd | 抗菌剤 |
CN103156888A (zh) * | 2013-03-18 | 2013-06-19 | 广州知光生物科技有限公司 | 脆弱拟杆菌在制备治疗炎症性肠病组合物中的应用 |
CN106399141A (zh) * | 2015-07-31 | 2017-02-15 | 广州知易生物科技有限公司 | 一种脆弱拟杆菌及其应用 |
Non-Patent Citations (1)
Title |
---|
An antimicrobial protein of the gut symbiont Bacteroides fragilis with a MACPF domain of host immune proteins;Maria Chatzidaki-Livanis等;《Molecular Microbiology》;20141114;第94卷(第6期);1361-1374页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105434477A (zh) | 2016-03-30 |
WO2017071346A1 (zh) | 2017-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105434477B (zh) | 脆弱拟杆菌在抗水产病原菌中的应用 | |
CN106399141B (zh) | 一种脆弱拟杆菌及其应用 | |
CN111534446B (zh) | 罗伊氏乳杆菌及其应用 | |
CN105543126A (zh) | 一种植物乳杆菌jm113及其应用 | |
CN102533618A (zh) | 一种植物乳杆菌ccfm8724及其用途 | |
CN1186440C (zh) | 预防病原性细菌引起的腹泻的新双歧杆菌 | |
CN105008526A (zh) | 新颖噬菌体和包括所述新颖噬菌体的抗细菌组成物 | |
CN107267408A (zh) | 一种唾液乳杆菌jm55及其应用 | |
CN113122466B (zh) | 粪肠球菌及其应用 | |
CN113040390B (zh) | 一株益生、耐盐约氏乳杆菌及其在畜禽水产养殖中防治病原菌的应用 | |
CN114292781B (zh) | 一种长双歧杆菌sysu-02及其应用 | |
CN103409334B (zh) | 抑制阴道炎病原菌之乳酸杆菌及其用途 | |
CN113583972A (zh) | 一株可降低抗生素耐药性的大肠杆菌噬菌体及其应用 | |
CN113755450A (zh) | 一株大肠杆菌噬菌体gn4-1及其应用 | |
CN111387506A (zh) | 一种嗜酸乳杆菌的用途及含所述嗜酸乳杆菌的组合物 | |
CN114480214A (zh) | 一株西藏阿里牦牛奶疙瘩中分离的副干酪乳杆菌及应用 | |
CN110004072A (zh) | 一株益生性粪肠球菌分离株a3-1及其应用 | |
CN110004096A (zh) | 一株植物乳杆菌及其应用 | |
CN101492650B (zh) | 一种抗猪链球菌细菌素及其生产方法与专用菌株 | |
CN113862181A (zh) | 一种具有肠道调节功能的乳双歧杆菌株rk-7782及其应用 | |
CN113151035A (zh) | 一种解淀粉芽孢杆菌、筛选方法、鉴定方法及应用 | |
CN106389475B (zh) | 脆弱拟杆菌在预防和/或治疗脑膜炎中的应用 | |
CN100413958C (zh) | 具有抗肠道致病菌和抗氧化特性的双歧杆菌及其用途 | |
CN103952357B (zh) | 一种高效抑制禽源弯曲杆菌的唾液乳酸杆菌 | |
CN106387314A (zh) | 脆弱拟杆菌在动物养殖中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170705 Address after: 510663 Guangdong province high tech Industrial Development Zone of Guangzhou Science City on Guangzhou Road No. 3 international business incubator F F319 room Applicant after: Guangzhou puwell sincessta Pharmaceutical Co. Ltd. Address before: 510663 Guangdong city of Guangzhou province Luogang District Science City Moon Road No. 3 international business incubator building F room 319 Applicant before: Guangzhou Zhiyi Biological Technology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220118 Address after: 510663 3rd floor, building a, No.2 Ruitai Road, Guangzhou high tech Industrial Development Zone, Guangzhou City, Guangdong Province Patentee after: GUANGZHOU ZHIYI PHARMACEUTICAL, Inc. Address before: 510663 room f319, zone F, Guangzhou International Business Incubator, No. 3, lanyue Road, Science City, Guangzhou high tech Industrial Development Zone, Guangdong Province Patentee before: GUANGZHOU PROFORCARE PHARMACEUTICALS Inc. |
|
TR01 | Transfer of patent right |